Glucocorticoid-induced osteoporosis: pathogenesis and prevention
Osteoporosis (OP) along with myocardial infarction, oncological diseases and expected death takes the lead in the general morbidity and mortality profile of population. The indicators of primary and general incidence of OP are markedly different in the regions of Russia according to the Healthcare M...
Main Authors: | I. G. Krasivina, L. N. Dolgova, N. V. Dolgov, A. A. Larina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2020-01-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/5484 |
Similar Items
-
REVIEW OF AMERICAN COLLEGE OF RHEUMATOLOGY (ACR) CLINICAL GUIDELINES FOR THE PREVENTION AND TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS
by: N. V. Toroptsova
Published: (2018-05-01) -
Analysis of the state-of-the-art of consulting medical care to patients with glucocorticoid-induced osteoporosis or its risk according to the data of a questionnaire survey (GLUCOST study)
by: I A Baranova, et al.
Published: (2015-05-01) -
GLUCOCORTICOID-INDUCED OSTEOPOROSIS: PATHOGENESIS, PREVENTION, TREATMENT
by: Irina Aleksandrovna Baranova
Published: (2010-06-01) -
Glucocorticoid-induced osteoporosis: 2013 update
by: M. Mazzantini, et al.
Published: (2014-07-01) -
New possibilities for the treatment of glucocorticoid-induced osteoporosis
by: I.A. Baranova
Published: (2014-05-01)